ClearPoint Neuro, Inc. (CLPT)
USD 12.14
(-7.3%)
USD 12.14
(-7.3%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -22.44 Million USD | -37.44% |
| 2022 | -16.33 Million USD | -22.12% |
| 2021 | -13.37 Million USD | -115.02% |
| 2020 | -6.22 Million USD | -35.4% |
| 2019 | -4.59 Million USD | 12.46% |
| 2018 | -5.24 Million USD | 17.17% |
| 2017 | -6.33 Million USD | 15.4% |
| 2016 | -7.48 Million USD | 16.55% |
| 2015 | -8.97 Million USD | -68.67% |
| 2014 | -5.32 Million USD | 28.82% |
| 2013 | -7.47 Million USD | -138.87% |
| 2012 | -3.12 Million USD | 47.15% |
| 2011 | -5.92 Million USD | 37.77% |
| 2010 | -9.51 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -4.73 Million USD | -12.01% |
| 2024 Q1 | -4.23 Million USD | 10.09% |
| 2023 Q4 | -4.7 Million USD | 3.9% |
| 2023 Q1 | -5.71 Million USD | -27.81% |
| 2023 Q3 | -4.89 Million USD | 31.33% |
| 2023 Q2 | -7.13 Million USD | -24.84% |
| 2023 FY | -22.44 Million USD | -37.44% |
| 2022 Q3 | -3.79 Million USD | 9.73% |
| 2022 Q4 | -4.46 Million USD | -17.76% |
| 2022 Q1 | -3.86 Million USD | 2.96% |
| 2022 Q2 | -4.2 Million USD | -8.8% |
| 2022 FY | -16.33 Million USD | -22.12% |
| 2021 Q2 | -3.4 Million USD | -56.21% |
| 2021 FY | -13.37 Million USD | -115.02% |
| 2021 Q4 | -3.98 Million USD | -4.68% |
| 2021 Q1 | -2.18 Million USD | 3.71% |
| 2021 Q3 | -3.8 Million USD | -11.65% |
| 2020 Q2 | -1.47 Million USD | -22.05% |
| 2020 Q1 | -1.2 Million USD | 14.91% |
| 2020 Q4 | -2.26 Million USD | -78.14% |
| 2020 Q3 | -1.27 Million USD | 13.78% |
| 2020 FY | -6.22 Million USD | -35.4% |
| 2019 Q3 | -910.52 Thousand USD | 29.58% |
| 2019 Q4 | -1.42 Million USD | -55.96% |
| 2019 FY | -4.59 Million USD | 12.46% |
| 2019 Q1 | -972.24 Thousand USD | 0.69% |
| 2019 Q2 | -1.29 Million USD | -33.0% |
| 2018 Q2 | -1.63 Million USD | -14.63% |
| 2018 FY | -5.24 Million USD | 17.17% |
| 2018 Q4 | -979.02 Thousand USD | 18.83% |
| 2018 Q1 | -1.42 Million USD | 22.14% |
| 2018 Q3 | -1.2 Million USD | 26.27% |
| 2017 Q3 | -1.32 Million USD | 27.16% |
| 2017 FY | -6.33 Million USD | 15.4% |
| 2017 Q1 | -1.35 Million USD | 24.39% |
| 2017 Q2 | -1.82 Million USD | -34.62% |
| 2017 Q4 | -1.83 Million USD | -38.08% |
| 2016 Q3 | -1.7 Million USD | 16.82% |
| 2016 Q2 | -2.05 Million USD | -6.27% |
| 2016 Q1 | -1.93 Million USD | -36.21% |
| 2016 FY | -7.48 Million USD | 16.55% |
| 2016 Q4 | -1.79 Million USD | -4.72% |
| 2015 FY | -8.97 Million USD | -68.67% |
| 2015 Q4 | -1.41 Million USD | 26.33% |
| 2015 Q3 | -1.92 Million USD | 28.17% |
| 2015 Q2 | -2.68 Million USD | 8.9% |
| 2015 Q1 | -2.94 Million USD | -9.93% |
| 2014 Q3 | -2.61 Million USD | -18.18% |
| 2014 Q1 | 2.19 Million USD | 205.99% |
| 2014 Q4 | -2.67 Million USD | -2.31% |
| 2014 FY | -5.32 Million USD | 28.82% |
| 2014 Q2 | -2.21 Million USD | -201.07% |
| 2013 Q4 | -2.06 Million USD | -11.12% |
| 2013 FY | -7.47 Million USD | -138.87% |
| 2013 Q1 | -1.36 Million USD | -184.05% |
| 2013 Q2 | -2.17 Million USD | -59.34% |
| 2013 Q3 | -1.86 Million USD | 14.56% |
| 2012 Q4 | -481.27 Thousand USD | 52.68% |
| 2012 Q2 | -479.52 Thousand USD | 58.35% |
| 2012 Q1 | -1.15 Million USD | 12.2% |
| 2012 FY | -3.12 Million USD | 47.15% |
| 2012 Q3 | -1.01 Million USD | -112.09% |
| 2011 FY | -5.92 Million USD | 37.77% |
| 2011 Q3 | -1.43 Million USD | 2.81% |
| 2011 Q4 | -1.31 Million USD | 8.34% |
| 2011 Q2 | -1.47 Million USD | 0.0% |
| 2010 FY | -9.51 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -56.298% |
| Cerus Corporation | -30.05 Million USD | 25.312% |
| OrthoPediatrics Corp. | -25.76 Million USD | 12.885% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -111.329% |
| Talis Biomedical Corporation | -66.81 Million USD | 66.406% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -29.776% |
| Inogen, Inc. | -109.38 Million USD | 79.48% |
| Spectral AI, Inc. | -12.98 Million USD | -72.874% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 64.137% |
| CVRx, Inc. | -43.1 Million USD | 47.925% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -536.224% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -80.608% |
| Orthofix Medical Inc. | -139.11 Million USD | 83.865% |
| Venus Concept Inc. | -28.3 Million USD | 20.711% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 58.455% |
| Bioventus Inc. | -81.72 Million USD | 72.535% |
| BrainsWay Ltd. | -4.92 Million USD | -355.571% |
| Envoy Medical, Inc. | -18.37 Million USD | -22.182% |
| electroCore, Inc. | -18.8 Million USD | -19.362% |
| IceCure Medical Ltd | -15.57 Million USD | -44.106% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 53.702% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -29.986% |
| MaxCyte, Inc. | -48.29 Million USD | 53.527% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -87.75% |
| Nexalin Technology, Inc. | -5.69 Million USD | -294.046% |
| PAVmed Inc | -68.79 Million USD | 67.373% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 60.317% |
| RxSight, Inc. | -50.08 Million USD | 55.184% |
| Sight Sciences, Inc. | -57.27 Million USD | 60.809% |
| SI-BONE, Inc. | -46.93 Million USD | 52.172% |
| TELA Bio, Inc. | -44.07 Million USD | 49.073% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 58.548% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 56.355% |
| LivaNova PLC | -68.49 Million USD | 67.231% |
| 908 Devices Inc. | -42.75 Million USD | 47.505% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 87.055% |
| Nemaura Medical Inc. | -9.59 Million USD | -133.929% |
| NeuroPace, Inc. | -27.17 Million USD | 17.399% |
| LENSAR, Inc. | -12.22 Million USD | -83.547% |
| Apyx Medical Corporation | -17.25 Million USD | -30.054% |
| Cutera, Inc. | -156.23 Million USD | 85.633% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -160.879% |
| BioSig Technologies, Inc. | -28.51 Million USD | 21.275% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 74.388% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 120.126% |
| Axonics, Inc. | -26.05 Million USD | 13.858% |
| Outset Medical, Inc. | -169.77 Million USD | 86.779% |
| IRIDEX Corporation | -10 Million USD | -124.303% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 79.439% |
| IRadimed Corporation | 20.03 Million USD | 212.031% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -172.238% |
| INVO Bioscience, Inc. | -6.76 Million USD | -231.69% |
| Telesis Bio, Inc. | -35.15 Million USD | 36.142% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 256.636% |
| Varex Imaging Corporation | 32.1 Million USD | 169.925% |
| Quipt Home Medical Corp. | 3.91 Million USD | 672.748% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -85.0% |
| Pulmonx Corporation | -61.93 Million USD | 63.759% |
| Dynatronics Corporation | -2.27 Million USD | -887.485% |
| Modular Medical, Inc. | -17.52 Million USD | -28.051% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -53.33% |
| Semler Scientific, Inc. | 22.25 Million USD | 200.854% |
| InMode Ltd. | 195.66 Million USD | 111.472% |
| Bruker Corporation | 436.9 Million USD | 105.138% |
| Cytosorbents Corporation | -31.2 Million USD | 28.079% |
| DexCom, Inc. | 597.7 Million USD | 103.755% |
| Align Technology, Inc. | 643.33 Million USD | 103.489% |
| Viveve Medical, Inc. | -21.55 Million USD | -4.143% |
| ZimVie Inc. | -30.93 Million USD | 27.451% |
| Movano Inc. | -29.69 Million USD | 24.399% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 19.389% |
| Nexalin Technology, Inc. | -5.69 Million USD | -294.046% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -536.224% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 90.376% |
| Profound Medical Corp. | -28.61 Million USD | 21.561% |
| Insulet Corporation | 220 Million USD | 110.203% |
| enVVeno Medical Corporation | -25.23 Million USD | 11.063% |
| Surmodics, Inc. | -5.64 Million USD | -297.626% |
| iCAD, Inc. | -7.68 Million USD | -191.924% |
| Nuwellis, Inc. | -17.63 Million USD | -27.317% |
| Biotricity, Inc. | -8.82 Million USD | -154.251% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 82.066% |
| Aethlon Medical, Inc. | -12.63 Million USD | -77.627% |
| InspireMD, Inc. | -21.14 Million USD | -6.163% |
| PAVmed Inc. | -68.79 Million USD | 67.373% |
| BIOLASE, Inc. | -17.93 Million USD | -25.138% |
| Beyond Air, Inc. | -63 Million USD | 64.375% |
| FONAR Corporation | 16.53 Million USD | 235.745% |
| AxoGen, Inc. | -21.46 Million USD | -4.585% |
| Vivani Medical, Inc. | -26.96 Million USD | 16.759% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 224.417% |
| Inari Medical, Inc. | -14.03 Million USD | -59.963% |
| UFP Technologies, Inc. | 57.66 Million USD | 138.925% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -355.516% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -255.96% |
| Tenon Medical, Inc. | -15.72 Million USD | -42.723% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -200.321% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 47.441% |
| AdaptHealth Corp. | -598.4 Million USD | 96.249% |
| Sintx Technologies, Inc. | -13.35 Million USD | -68.034% |
| NanoVibronix, Inc. | -3.43 Million USD | -553.26% |
| Quanterix Corporation | -49.7 Million USD | 54.838% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -85.0% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -5775.916% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 93.289% |
| TransMedics Group, Inc. | -28.72 Million USD | 21.864% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 4.938% |
| NeuroMetrix, Inc. | -7.15 Million USD | -213.863% |
| Hyperfine, Inc. | -48.11 Million USD | 53.349% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 65.481% |
| Biomerica, Inc. | -6.36 Million USD | -252.537% |
| Bone Biologics Corporation | -9.42 Million USD | -138.07% |
| AVITA Medical, Inc. | -40.4 Million USD | 44.443% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -117.685% |
| Silk Road Medical, Inc | -59.27 Million USD | 62.13% |